Meropenem contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Meropenem}} {{CMG}} ==Contraindications== Meropenem I.V. is contraindicated in patients with known hypersensitivity to any component of this product or to other...")
 
No edit summary
Line 5: Line 5:
==Contraindications==
==Contraindications==


Meropenem I.V. is contraindicated in patients with  known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to β-lactams.
Meropenem I.V. is contraindicated in patients with  known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to β-lactams.<ref>{{Cite web | last = | first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf | publisher = |date = | accessdate = }}</ref>
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Antibiotics]]
[[Category:Wikinfect]]

Revision as of 22:09, 20 December 2013

Meropenem
MERREM® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Compatibility, Reconstitution, and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Contraindications

Meropenem I.V. is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to β-lactams.[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.